Assessing Efficacy of Intravenous Acetaminophen for Perioperative Pain Treatment in Spinal Surgery

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05764707
Collaborator
(none)
60
1
2
36.8
1.6

Study Details

Study Description

Brief Summary

Spinal surgeries are generally associated with intense pain in the postoperative period, especially for the initial few days. The aim of this study is to examine the effect of intraoperative intravenous acetaminophen in spine surgery on postoperative analgesic requirements, pain scores, patient satisfaction, and clinical recovery. Enrolled patients are randomized to receive either intravenous acetaminophen or placebo at the time of surgical closure. It is hypothesized that patients receiving intravenous acetaminophen will have improved pain scores, require less opiate medication, and have better patient satisfaction than those receiving placebo.

Condition or Disease Intervention/Treatment Phase
Phase 2

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Assessing Efficacy of Intravenous Acetaminophen for Perioperative Pain Treatment in Spinal Surgery
Actual Study Start Date :
Jan 10, 2020
Actual Primary Completion Date :
Jan 31, 2023
Actual Study Completion Date :
Feb 3, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intravenous Acetaminophen

Intravenous acetaminophen (1000mg) will be administered within 30 minutes of skin closure.

Drug: Acetaminophen
Patients will received 1000mg of intravenous acetaminophen within 30 minutes of skin closure.
Other Names:
  • Tylenol
  • Placebo Comparator: Intravenous Placebo

    Intravenous normal saline will be administered within 30 minutes of skin closure.

    Drug: Placebo
    Patients will received 1000mg of normal saline within 30 minutes of skin closure.
    Other Names:
  • Normal Saline
  • Outcome Measures

    Primary Outcome Measures

    1. Worst pain score in the post-anesthesia care unit [Time of postoperative care unit discharge readiness, approximately 3 hours]

      The primary outcome will assess worst pain score at the time the patient is ready for post anesthesia care unit discharge using the Revised American Pain Society Patient Outcome Questionnaire. This scale ranges from 0 to 10, with higher values reporting more pain.

    Secondary Outcome Measures

    1. Postoperative pain scores [Postoperatively until 72 hours or discharge, approximately three days]

      Pain scores will be collected for the first 72 hours or up until discharge, whichever comes first, using clinically documented nursing pain scores. Values will be collected on a scale from 0 to 10 with higher values indicating increased (worst) pain.

    2. Intraoperative opioid consumption [Intraoperatively]

      Total cumulative morphine equivalents will be reported while the patient is in the operating room.

    3. Postoperative opioid consumption in the post anesthesia care unit [Postoperatively until time of PACU discharge, approximately 3 hours.]

      Total cumulative morphine equivalents will be reported while the patient is in the post anesthesia care unit.

    4. Postoperative opioid consumption after discharge from the postoperative care [Time of discharge from the postoperative care unit until discharge from the hospital, an average of two days]

      Total cumulative morphine equivalents will be reported starting from the time the patient is discharged from the post anesthesia care unit until they are discharged from the hospital.

    5. Time to rescue analgesia [Postoperatively until discharge, an average of two days]

      The time to rescue analgesia (in minutes) will be assessed.

    6. Patient satisfaction [Time of postoperative care unit discharge readiness, approximately 3 hours.]

      Satisfaction with the patient's pain treatment in the hospital will be assessed at the time the patient is ready for discharge from the post anesthesia care unit using the Revised American Pain Society Patient Outcome Questionnaire. This scale ranges from 0 (extremely dissatisfied) to 10 (extremely satisfied).

    7. Length of hospital stay [Postoperatively until discharge, an average of two days]

      Length of hospital stay (in days) will be reported.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients undergoing 1-2 levels primary spine surgery ≥18 years old
    Exclusion Criteria:
    • Chronic opiate users

    • More than 3 levels or revision spine surgery

    • Liver disease patients include elevated LFT, hepatitis A, hepatitis B or hepatitis C, cirrhosis, fatty liver disease, and any other liver diseases caused by drugs, poisons, or alcohol(s)

    • Allergy/hypersensitivity to acetaminophen

    • Patients that have used acetaminophen during the 24 hours before their scheduled surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Massachusetts General Hospital Boston Massachusetts United States 02214

    Sponsors and Collaborators

    • Massachusetts General Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jingping Wang, MD, Ph.D., Associate Professor of Anaesthesia, Massachusetts General Hospital
    ClinicalTrials.gov Identifier:
    NCT05764707
    Other Study ID Numbers:
    • 2019P002750
    First Posted:
    Mar 13, 2023
    Last Update Posted:
    Mar 13, 2023
    Last Verified:
    Mar 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    Yes
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 13, 2023